The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Systemic and Nasal Delivery of Orexin-A (Hypocretin-1) Reduces the Effects of Sleep Deprivation on Cognitive Performance in Nonhuman Primates
Open accessAbstract
Hypocretin-1 (orexin-A) was administered to sleep-deprived (30–36 h) rhesus monkeys immediately preceding testing on a multi-image delayed match-to-sample (DMS) short-term memory task. The DMS task used multiple delays and stimulus images and effectively measures cognitive defects produced by sleep deprivation (Porrino et al., 2005). Two methods of administration of orexin-A were tested, intravenous injections (2.5–10.0 μg/kg, i.v.) and a novel method developed for nasal delivery via an atomizer spray mist to the nostrils (dose estimated 1.0 μg/kg). Results showed that orexin-A delivered via the intravenous and nasal routes significantly improved performance in sleep-deprived monkeys; however, the nasal delivery method was significantly more effective than the highest dose (10 μg/kg) of intravenous orexin-A tested. The improvement in performance by orexin-A was specific to trials classified as high versus low cognitive load as determined by performance difficulty under normal testing conditions. Except for the maximum intravenous dose (10 μg/kg), neither delivery method affected task performance in alert non-sleep-deprived animals. The improved performance in sleep-deprived animals was accompanied by orexin-A related alterations in local cerebral glucose metabolism (CMRglc) in specific brain regions shown previously to be engaged by the task and impaired by sleep deprivation (Porrino et al., 2005). Consistent with the differential effects on performance, nasal delivered orexin-A produced a more pronounced reversal of sleep deprivation induced changes in brain metabolic activity (CMRglc) than intravenous orexin-A. These findings provide strong evidence for the effectiveness of intranasal orexin-A in alleviating cognitive deficits produced by loss of sleep.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applied Linear Statistical Models
Ziegel, E. R., Neter, J., Wasserman, W., & Kutner, M. (1992) · Technometrics · doi:10.2307/1269588 · Cited by 9,907
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 2×
“Orexin cells are localized to the hypothalamus (Peyron et al., 1998; van den Pol et al., 1998; Nambu et al., 1999; Kilduff and Peyron, 2000; Fadel and Deutch, 2002).”
BackgroundNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 3×
“In addition several reports have demonstrated the correspondence between orexin-A release and the sleep-wake cycles of rodents, monkeys and humans (Edgar et al., 1993; Chemelli et al., 1999; Nishino et al., 2000; Taheri et al., 2000; Hara et al., 2001; Yoshida et al., 2001; Kiyashchenko et al., 2002; Wu et al., 2002;…”
BackgroundLin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,418
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. (2000) · Nature Medicine · doi:10.1038/79690 · Cited by 2,118
Reduced Number of Hypocretin Neurons in Human Narcolepsy
Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., & Siegel, J. M. (2000) · Neuron · doi:10.1016/s0896-6273(00)00058-1 · Cited by 2,089
Self-citationHypocretin (orexin) deficiency in human narcolepsy
Nishino, S., Ripley, B., Overeem, S., Lammers, G. J., & Mignot, E. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05582-8 · Cited by 1,776 · cited 3×
“In addition several reports have demonstrated the correspondence between orexin-A release and the sleep-wake cycles of rodents, monkeys and humans (Edgar et al., 1993; Chemelli et al., 1999; Nishino et al., 2000; Taheri et al., 2000; Hara et al., 2001; Yoshida et al., 2001; Kiyashchenko et al., 2002; Wu et al., 2002;…”
BackgroundMRI-PET Registration with Automated Algorithm
Woods, R. P., Mazziotta, J. C., & R. Cherry, A. S. (1993) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199307000-00004 · Cited by 1,617
Genetic Ablation of Orexin Neurons in Mice Results in Narcolepsy, Hypophagia, and Obesity
Hara, J., Beuckmann, C. T., Nambu, T., Willie, J. T., Chemelli, R. M., Sinton, C. M., Sugiyama, F., Yagami, K.-I., Goto, K., Yanagisawa, M., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00293-8 · Cited by 1,403
Orexin A activates locus coeruleus cell firing and increases arousal in the rat
Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10911 · Cited by 1,234 · cited 4×
“…brain regions making it possible for this peptide, once released, to activate a large number of areas affected by sleep and sleep deprivation (Hagan et al., 1999; Bourgin et al., 2000; Kilduff and Peyron, 2000; Piper et al., 2000; Gerashchenko et al., 2001; Yoshida et al., 2001; Wu et al.,…”
BackgroundInfluentialCELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO
Trombetta, E. S., & Mellman, I. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104538 · Cited by 1,173
Distribution of orexin neurons in the adult rat brain
Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisawa, M., & Goto, K. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01336-0 · Cited by 1,068
Thomas, M., Sing, H., Belenky, G., Holcomb, H., Mayberg, H., Dannals, R., Wagner JR., H., Thorne, D., Popp, K., Rowland, L., et al. (2000) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2000.00225.x · Cited by 1,066 · cited 1×
“6), a brain region highly susceptible to sleep deficits in humans (Thomas et al., 2000; Drummond and Brown, 2001; Lambe et al., 2005).”
BackgroundDischarge of Identified Orexin/Hypocretin Neurons across the Sleep-Waking Cycle
Lee, M. G., Hassani, O. K., & Jones, B. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1887-05.2005 · Cited by 871
Behavioral Correlates of Activity in Identified Hypocretin/Orexin Neurons
Mileykovskiy, B. Y., Kiyashchenko, L. I., & Siegel, J. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.035 · Cited by 848
Self-citationEdgar, D., Dement, W., & Fuller, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-03-01065.1993 · Cited by 666
Promotion of sleep by targeting the orexin system in rats, dogs and humans
Brisbare-Roch, C., Dingemanse, J., Koberstein, R., Hoever, P., Aissaoui, H., Flores, S., Mueller, C., Nayler, O., van Gerven, J., de Haas, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1544 · Cited by 573
Hypocretin (orexin) cell loss in Parkinson's disease
Thannickal, T. C., Lai, Y.-Y., & Siegel, J. M. (2007) · Brain · doi:10.1093/brain/awm097 · Cited by 566
Self-citationvan den Pol, A. N., Gao, X.-B., Obrietan, K., Kilduff, T. S., & Belousov, A. B. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07962.1998 · Cited by 552
Hypothalamic Hypocretin (Orexin): Robust Innervation of the Spinal Cord
van den Pol, A. N. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03171.1999 · Cited by 526
Hypocretin-1 Modulates Rapid Eye Movement Sleep through Activation of Locus Coeruleus Neurons
Bourgin, P., Huitrón-Reséndiz, S., Spier, A. D., Fabre, V., Morte, B., Criado, J. R., Sutcliffe, J. G., Henriksen, S. J., & de Lecea, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07760.2000 · Cited by 508
Fadel, J., & Deutch, A. Y. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00017-9 · Cited by 503
Hypocretin (orexin) loss in Parkinson's disease
Fronczek, R., Overeem, S., Lee, S. Y. Y., Hegeman, I. M., van Pelt, J., van Duinen, S. G., Lammers, G. J., & Swaab, D. F. (2007) · Brain · doi:10.1093/brain/awm090 · Cited by 463
Yoshida, Y., Fujiki, N., Nakajima, T., Ripley, B., Matsumura, H., Yoneda, H., Mignot, E., & Nishino, S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01725.x · Cited by 448
The hypocretin/orexin ligand–receptor system: implications for sleep and sleep disorders
Kilduff, T. S., & Peyron, C. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01594-0 · Cited by 438
Gelenberg, A. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0101 · Cited by 356
The novel brain neuropeptide, orexin‐A, modulates the sleep–wake cycle of rats
Piper, D. C., Upton, N., Smith, M. I., & Hunter, A. J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00919.x · Cited by 351
Mieda, M., Willie, J. T., Hara, J., Sinton, C. M., Sakurai, T., & Yanagisawa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400590101 · Cited by 341
Release of Hypocretin (Orexin) during Waking and Sleep States
Kiyashchenko, L. I., Mileykovskiy, B. Y., Maidment, N., Lam, H. A., Wu, M.-F., John, J., Peever, J., & Siegel, J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05282.2002 · Cited by 340
Self-citationOrexin A but Not Orexin B Rapidly Enters Brain from Blood by Simple Diffusion
Kastin, A. J., & Akerstrom, V. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38126-1 · Cited by 323
SB‐334867‐A: the first selective orexin‐1 receptor antagonist
Smart, D., Sabido‐David, C., Brough, S. J., Jewitt, F., Johns, A., Porter, R. A., & Jerman, J. C. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703953 · Cited by 308
The Effects of Total Sleep Deprivation on Cerebral Responses to Cognitive Performance
Drummond, S. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00325-6 · Cited by 306
Zeitzer, J. M., Buckmaster, C. L., Parker, K. J., Hauck, C. M., Lyons, D. M., & Mignot, E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03555.2003 · Cited by 277
Gerashchenko, D., Kohls, M. D., Greco, M., Waleh, N. S., Salin-Pascual, R., Kilduff, T. S., Lappi, D. A., & Shiromani, P. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07273.2001 · Cited by 272
Local cerebral glucose utilization in the normal conscious macaque monkey
Kennedy, C., Sakurada, O., Shinohara, M., Jehle, J., & Sokoloff, L. (1978) · Annals of Neurology · doi:10.1002/ana.410040402 · Cited by 246
The neurotransmitters of sleep.
Siegel, J. M. (2004) · PubMed · Cited by 211
Self-citationTakikawa, S., Dhawan, V, Spetsieris, P., Robeson, W., Chaly, T., Dahl, R., Margouleff, D., & Eidelberg, D. (1993) · Radiology · doi:10.1148/radiology.188.1.8511286 · Cited by 208
Vittoz, N. M., & Berridge, C. W. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300807 · Cited by 191
Taheri, S., Sunter, D., Dakin, C., Moyes, S., Seal, L., Gardiner, J., Rossi, M., Ghatei, M., & Bloom, S. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00955-6 · Cited by 174
Porrino, L. J., Daunais, J. B., Rogers, G. A., Hampson, R. E., & Deadwyler, S. A. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030299 · Cited by 160
Self-citationWu, M.-F., John, J., Maidment, N. T., Lam, H. A., & Siegel, J. M. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00207.2002 · Cited by 160
Self-citationPeptides crossing the blood–brain barrier: some unusual observations
Kastin, A. J., Pan, W., Maness, L. M., & Banks, W. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01961-7 · Cited by 156
John, J., Wu, M. F., & Siegel, J. M. (2000) · PubMed · Cited by 141
Self-citationLambe, E. K., Olausson, P., Horst, N. K., Taylor, J. R., & Aghajanian, G. K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0719-05.2005 · Cited by 135
Akbari, E., Naghdi, N., & Motamedi, F. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.028 · Cited by 127
Binding interactions between peptides and proteins of the class II Major Histocompatibility Complex
McFarland, B. J., & Beeson, C. (2002) · Medicinal Research Reviews · doi:10.1002/med.10006 · Cited by 126
Categorization in the monkey hippocampus: A possible mechanism for encoding information into memory
Hampson, R. E., Pons, T. P., Stanford, T. R., & Deadwyler, S. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400162101 · Cited by 126
Self-citationKiyashchenko, L. I., Mileykovskiy, B. Y., Lai, Y.-Y., & Siegel, J. M. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.5.2008 · Cited by 115
Self-citationPeever, J. H., Lai, Y., & Siegel, J. M. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00968.2002 · Cited by 100
Self-citationSB-334867-A antagonises orexin mediated excitation in the locus coeruleus
Soffin, E. M., Evans, M. L., Gill, C. H., Harries, M. H., Benham, C. D., & Davies, C. H. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00156-3 · Cited by 89
Rasmussen, K., Hsu, M.-A., & Yang, Y. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301239 · Cited by 64
Template Images for Nonhuman Primate Neuroimaging: 2. Macaque
BLACK, K. J., Koller, J. M., Snyder, A. Z., & Perlmutter, J. S. (2001) · NeuroImage · doi:10.1006/nimg.2001.0871 · Cited by 58
John, J., Wu, M.-F., Kodama, T., & Siegel, J. M. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00557.x · Cited by 50
Self-citationHorvath (1999) · doi:10.1002/(sici)1096-9861(19991213)415:2
Cited by
Intranasal delivery of biologics to the central nervous system
Lochhead, J. J., & Thorne, R. G. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.002 · Cited by 1,214
Evaluation of intranasal delivery route of drug administration for brain targeting
Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 744
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System
Tsujino, N., & Sakurai, T. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001321 · Cited by 479
Intranasal Treatment of Central Nervous System Dysfunction in Humans
Chapman, C. D., Frey, W. H., Craft, S., Danielyan, L., Hallschmid, M., Schiöth, H. B., & Benedict, C. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0915-1 · Cited by 310
Metadata
- Authors
- Deadwyler, S. A., Porrino, L., Siegel, J. M., & Hampson, R. E.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-12-26
- Volume
- 27
- Issue
- 52
- Pages
- 14239-14247
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2014031369
- Cited by
- 265
- References
- 56
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.